Cholestyramine and intestinal obstruction.
D002779:Cholestasis / Q000188:drug therapy; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007415:Intestinal Obstruction / Q000139:chemically induced*; D014280:Triglycerides / Q000378:metabolism
D014280:Triglycerides; D002792:Cholestyramine Resin